| Marsha L Chaffins, MD | |
|
Henry Ford Health System, 3031 West Grand Blvd., Detroit, MI 48202 | |
| (313) 916-2454 | |
| Not Available |
| Full Name | Marsha L Chaffins |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 35 Years |
| Location | Henry Ford Health System, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184702219 | NPI | - | NPPES |
| 700H262200 | Other | BLUE CROSS-BLUE CROSS | |
| 294802010 | Medicaid | MI | |
| MC054211 | Other | COMMERCIAL-COMMERCIAL NUMBER | |
| MC054211 | Other | CHAMPUS-CHAMPUS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | 054211 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Ford Medical Group | 0547178311 | 2095 |
News Archive
A poster session presented by The University of Texas M. D. Anderson Cancer Center at the Oncology Nurses Society 33rd Annual Congress, found that early nursing intervention and implementation of effective strategies can lead to a decrease in the incidence of lymphedema, better management of chronic lymphedema and improved quality of life in breast cancer patients.
Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.
A new study by a University of Arkansas biomedical engineer and his colleagues at the National Cancer Institute demonstrates further promise for chitosan/interleukin-12 as an effective anti-tumor immunotherapy.
A study led by researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at St. Paul's Hospital and the University of British Columbia has found that supervised injection facilities such as Vancouver's Insite connect clients with addiction treatment, which in turn resulted in greater likelihood of stopping injection drug use for at least six months.
› Verified 1 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730252339 PECOS PAC ID: 0547178311 Enrollment ID: O20031111000124 |
News Archive
A poster session presented by The University of Texas M. D. Anderson Cancer Center at the Oncology Nurses Society 33rd Annual Congress, found that early nursing intervention and implementation of effective strategies can lead to a decrease in the incidence of lymphedema, better management of chronic lymphedema and improved quality of life in breast cancer patients.
Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.
A new study by a University of Arkansas biomedical engineer and his colleagues at the National Cancer Institute demonstrates further promise for chitosan/interleukin-12 as an effective anti-tumor immunotherapy.
A study led by researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at St. Paul's Hospital and the University of British Columbia has found that supervised injection facilities such as Vancouver's Insite connect clients with addiction treatment, which in turn resulted in greater likelihood of stopping injection drug use for at least six months.
› Verified 1 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760437826 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000691 |
News Archive
A poster session presented by The University of Texas M. D. Anderson Cancer Center at the Oncology Nurses Society 33rd Annual Congress, found that early nursing intervention and implementation of effective strategies can lead to a decrease in the incidence of lymphedema, better management of chronic lymphedema and improved quality of life in breast cancer patients.
Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.
A new study by a University of Arkansas biomedical engineer and his colleagues at the National Cancer Institute demonstrates further promise for chitosan/interleukin-12 as an effective anti-tumor immunotherapy.
A study led by researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at St. Paul's Hospital and the University of British Columbia has found that supervised injection facilities such as Vancouver's Insite connect clients with addiction treatment, which in turn resulted in greater likelihood of stopping injection drug use for at least six months.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marsha L Chaffins, MD Henry Ford Health System, 3031 West Grand Blvd., Detroit, MI 48202 Ph: (313) 916-2454 | Marsha L Chaffins, MD Henry Ford Health System, 3031 West Grand Blvd., Detroit, MI 48202 Ph: (313) 916-2454 |
News Archive
A poster session presented by The University of Texas M. D. Anderson Cancer Center at the Oncology Nurses Society 33rd Annual Congress, found that early nursing intervention and implementation of effective strategies can lead to a decrease in the incidence of lymphedema, better management of chronic lymphedema and improved quality of life in breast cancer patients.
Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.
A new study by a University of Arkansas biomedical engineer and his colleagues at the National Cancer Institute demonstrates further promise for chitosan/interleukin-12 as an effective anti-tumor immunotherapy.
A study led by researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at St. Paul's Hospital and the University of British Columbia has found that supervised injection facilities such as Vancouver's Insite connect clients with addiction treatment, which in turn resulted in greater likelihood of stopping injection drug use for at least six months.
› Verified 1 days ago
Dr. Laurie Linden Kohen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2171 | |
James A Brown, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 22151 Moross, Suite 234, Detroit, MI 48236 Phone: 313-885-5110 Fax: 313-885-8755 | |
David M. Ozog, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2454 | |
Dr. Emily L. Keimig, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Suite 800, Detroit, MI 48202 Phone: 313-916-2171 | |
Dr. Alison Tisack Boucher, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2151 | |
Dr. Snehal R Desai, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Suite 800, Detroit, MI 48202 Phone: 313-916-2171 |